Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
A research study to observe the safety, efficacy and tolerability of switching from Tenofovir
Disoproxil Fumarate to Besifovir dipivoxil maleate in patients with chronic hepatitis B